Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12345678910...
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Cancer 2016 NCI NIH-16-012 CDC $677,839
Cancer 2016 NCI NIH-16-013 CDC CPCRN $678,889
Cancer 2016 NCI NIH-16-015 NCTOH $68,807
Cancer 2016 NCI NIH-16-027 CDC $183,486
Cancer 2016 NCI NIH-16-029 IHS NARCH $240,000
Cancer 2016 NCI 5R01CA154739-05 Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics CLEVELAND, JOHN H. LEE MOFFITT CANCER CTR & RES INST FL $598,617
Cancer 2016 NCI 5R03CA182552-02 A novel regimen to target both pancreatic cancer K-ras and antiapoptotic proteins LI, FENGZHI ROSWELL PARK CANCER INSTITUTE CORP NY $84,900
Cancer 2016 NIGMS 1P20GM109024-01A1 5952 Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer MALLIK, SANKU NORTH DAKOTA STATE UNIVERSITY ND $867,444
Cancer 2016 NIGMS 1P20GM109024-01A1 5953 Animal Core Facility GUO, BIN NORTH DAKOTA STATE UNIVERSITY ND $407,028
Cancer 2016 NIGMS 1P20GM109024-01A1 5954 Nanoparticle-Powered Chemiluminescent Lateral Flow Biosensor Array for Early Diagnosis of Pancreatic Cancer LIU, GUODONG NORTH DAKOTA STATE UNIVERSITY ND $232,725
Cancer 2016 NIGMS 1P20GM109024-01A1 5955 Effects of salinomycin and binding target proteins in pancreatic cancer WU, ERXI NORTH DAKOTA STATE UNIVERSITY ND $232,725
Cancer 2016 NIGMS 1P20GM109024-01A1 5956 Combination Therapy: Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine REINDL, KATIE NORTH DAKOTA STATE UNIVERSITY ND $217,500
Cancer 2016 NIGMS 1P20GM109024-01A1 5957 Development of Monoclonal Antibodies to Inhibit RAGE Activation in Pancreatic Cancer tumors LECLERC, ESTELLE NORTH DAKOTA STATE UNIVERSITY ND $232,725
Cancer 2016 NIGMS 1P20GM113126-01 5963 Hepatic Stabilin-2 Mechanisms of Clearance HARRIS, EDWARD UNIVERSITY OF NEBRASKA LINCOLN NE $181,215
Cancer 2016 NIGMS 1P20GM113126-01 5964 Quantifying Biochemical Communication in Hepatocellular Carcinoma STAINS, CLIFF UNIVERSITY OF NEBRASKA LINCOLN NE $180,126
Cancer 2016 NIGMS 1P20GM109035-01A1 6003 Project 1: Incorporating Ethnic and Gender Disparities in Genomic Studies of Disease RAMACHANDRAN, SOHINI BROWN UNIVERSITY RI $279,489
Cancer 2016 NIGMS 1P20GM109035-01A1 6004 Project 2: Integrative Genomics of Cancer Survival HUANG, YEN-TSUNG BROWN UNIVERSITY RI $268,746
Cancer 2016 NIGMS 1P20GM113132-01 6070 Project 1: Proteomic approaches to target the PP6-mTORC2 pathway in glioblastoma KETTENBACH, ARMINJA DARTMOUTH COLLEGE NH $309,043
Cancer 2016 NIGMS 1P20GM113132-01 6072 Project 3: Protein Design for Selective Interference with LPA Signaling in Colon Cancer GRIGORYAN, GEVORG DARTMOUTH COLLEGE NH $274,177
Cancer 2016 NINDS 4R44NS071879-04 Advancing a Glioma Immunotherapy EMERICH, DWAINE IN CYTU, INC. RI $879,408
Cancer 2016 NIGMS 1P20GM113226-01 6174 High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis DENG, ZHONG-BIN UNIVERSITY OF LOUISVILLE KY $184,680
Cancer 2016 NCI 5R01CA175491-04 Improving prostate cancer screening by integration of SNPs with blood biomarkers KLEIN, ROBERT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $1
Cancer 2016 NCI 5R01CA077308-18 STAT Mediated TGF-a/EGFR Signaling in Squamous Cell Carcinomas of Head & Neck GRANDIS, JENNIFER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $321,866
Cancer 2016 NCI 5R01CA095684-13 Resistance of CML Stem Cells to Imatinib (Gleevec) BHATIA, RAVI UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $275,378
Cancer 2016 NCI 5R01CA160965-05 5-hydroxymethylcytosine in human cancer PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE MI $394,250
Cancer 2016 NHLBI 4R01HL112860-05 Endothelial Plasticity in Human Disease LIANG, OLIN RHODE ISLAND HOSPITAL RI $397,500
Cancer 2016 NCI 5R01CA154980-05 Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression VARAMBALLY, SOORYANARAYANA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $305,025
Cancer 2016 NCI 4R01CA177665-03 Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO) HUANG, CHUANSHU NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $351,713
Cancer 2016 NIA 4K24AG041180-05 Midcareer Mentoring Award for Patient-Oriented Research in Aging WALTER, LOUISE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $181,775
Cancer 2016 NHLBI 4R01HL118740-03 Preventing Anthracycline Cardiovascular Toxicity with Statins HUNDLEY, WILLIAM WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $900,665
Cancer 2016 NCI 5R01CA178394-03 Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy GAVATHIOTIS, EVRIPIDIS ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $346,525
Cancer 2016 NCI 1K22CA193660-01 Metabolic liabilities of cancer cells to the tumor nutrient environment BIRSOY, KIVANC ROCKEFELLER UNIVERSITY NY $206,064
Cancer 2016 NCI 1K22CA193860-01 PCOS, Type II diabetes and ovarian cancer risk HARRIS, HOLLY FRED HUTCHINSON CANCER RESEARCH CENTER WA $184,615
Cancer 2016 NCI 5R01CA098372-13 GPCR Signaling in SCCHN: Integration with EGFR GRANDIS, JENNIFER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $289,454
Cancer 2016 RMAP 4DP2OD008540-03 Exploring how the genome folds through proximity ligation and sequencing LIEBERMAN-AIDEN, EREZ BAYLOR COLLEGE OF MEDICINE TX $515,125
Cancer 2016 NIEHS 1R01ES024471-01A1 Role of Long Intergenic Noncoding RNA in UVB-induced Apoptosis and Skin Cancer SMART, ROBERT NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $335,832
Cancer 2016 NCI 1K22CA188181-01A1 Roles of Spartan in translesion synthesis and UV-induced carcinogenesis GHOSAL, GARGI UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $133,898
Cancer 2016 NCI 5K24CA160653-05 Midcareer Investigator Award FREEDLAND, STEPHEN CEDARS-SINAI MEDICAL CENTER CA $175,476
Cancer 2016 NCI 5R01CA177679-03 The role of adipocyte/macrophage fatty acid binding protein in breast cancer deve LI, BING UNIVERSITY OF LOUISVILLE KY $318,095
Cancer 2016 NCI 5R01CA180986-03 Prevention of Breast Cancer Development by Epidermal Fatty Acid Binding Protein ( LI, BING UNIVERSITY OF LOUISVILLE KY $318,580
Cancer 2016 NINDS 4R01NS073870-06 Defining the role of BRAF in glioma initiation and maintenance HOLMEN, SHERI UNIVERSITY OF UTAH UT $325,938
Cancer 2016 NCI 4F31CA180395-03 Biochemical and structural studies of HER2/ErbB2-containing heterodimers RAINES, LILY JOHNS HOPKINS UNIVERSITY MD $43,120
Cancer 2016 NIBIB 1R42EB019265-01A1 ARCHER - An Extremely Fast Medical Radiation Dose Computing Software XU, XIE VIRTUAL PHANTOMS, INC. NY $165,220
Cancer 2016 NIBIB 1R44EB023284-01A1 A high brightness microstructured anode X-ray source for clinical phase contrast imaging YUN, WENBING SIGRAY, INC. DE $224,812
Cancer 2016 NINDS 4U01NS082328-03 Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma ABOODY, KAREN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $1,238,896
Cancer 2016 NCATS 5UH3TR000961-03 Therapeutic Strategy for LAM (Lymphangioleiomyomatosis) EISSA, N BAYLOR COLLEGE OF MEDICINE TX $1,482,013
Cancer 2016 NCI 5F32CA180653-02 Cancer Specific Sensitivity to Suppression of Spliceosome Components PAOLELLA, BRENTON DANA-FARBER CANCER INST MA $58,002
Cancer 2016 NCI 5F31CA189651-02 Dissecting the Functional Roles of Two BH3-Binding Sites on Pro-Apoptotic BAX PRITZ, JONATHAN HARVARD MEDICAL SCHOOL MA $35,686
Cancer 2016 NCI 5K08CA184420-03 Sequence-based pathogen discovery in post-stem cell transplantation syndromes BHATT, AMI STANFORD UNIVERSITY CA $173,448
Cancer 2016 NCI 5R01CA181191-02 CT DOSE Collaboratory SMITH-BINDMAN, REBECCA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $1,139,030
Cancer 2016 NCI 2T32CA090217-16 Surgical Oncology Research Training Program GREENBERG, CAPRICE UNIVERSITY OF WISCONSIN-MADISON WI $398,287
Cancer 2016 NCI 5F31CA183493-03 Tumor expressed B7x accelerates disease and is a novel target for immunotherapy OHAEGBULAM, KIM ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $48,576
Cancer 2016 NCI 1R35CA196620-01 Molecular mechanisms of antibody-mediated immunotherapies RAVETCH, JEFFREY ROCKEFELLER UNIVERSITY NY $1,017,000
Cancer 2016 NIGMS 1U54GM115371-01 5353 Alterations and Renovations THOMAS, TIMOTHY ALASKA NATIVE TRIBAL HEALTH CONSORTIUM AK $310,430
Cancer 2016 NCI 1K22CA197014-01 Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma YANG, YIBIN RESEARCH INST OF FOX CHASE CAN CTR PA $194,616
Cancer 2016 NCI 1K22CA197058-01 BACH2 in Melanoma Development and Resistance KARRETH, FLORIAN H. LEE MOFFITT CANCER CTR & RES INST FL $177,344
Cancer 2016 NCI 1R01CA198291-01 Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer GIACCIA, AMATO STANFORD UNIVERSITY CA $507,772
Cancer 2016 NCI 1K22CA197074-01 Exosomic microRNAs and drug resistance in AML tumor microenvironment CHALLAGUNDLA, KISHORE UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $154,958
Cancer 2016 NCI 1R35CA197262-01 Molecular Biology of Oncogenic Papillomaviruses HOWLEY, PETER HARVARD MEDICAL SCHOOL MA $1,017,000
Cancer 2016 NCI 1R35CA197463-01 Discovery and Characterization of New Human Cancer Viruses MOORE, PATRICK UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $916,710
Cancer 2016 NCI 1R35CA197452-01 Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma FLORES, ELSA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $100,026
Cancer 2016 NCI 1R35CA197532-01 Mitochondrial metabolism and ROS regulate cancer CHANDEL, NAVDEEP NORTHWESTERN UNIVERSITY AT CHICAGO IL $914,370
Cancer 2016 NCI 1R35CA197465-01 Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance RONAI, ZE'EV SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $1,162,978
Cancer 2016 NCI 1R35CA197582-01 Cancer genes: translating basics to applications VOGT, PETER SCRIPPS RESEARCH INSTITUTE CA $1,062,495
Cancer 2016 NCI 1R35CA197585-01 Targeting breast cancer stem cells WICHA, MAX UNIVERSITY OF MICHIGAN MI $930,000
Cancer 2016 NCI 1R35CA197684-01 IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells BALDWIN, ALBERT UNIV OF NORTH CAROLINA CHAPEL HILL NC $848,325
Cancer 2016 NCI 1R35CA197605-01 Mucins and immune cell interactions in ovarian cancer pathogenesis & progression CRAMER, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,052,893
Cancer 2016 NCI 1R35CA197701-01 Imaging of Hematologic and Oncologic Disorders ROSS, BRIAN UNIVERSITY OF MICHIGAN MI $889,101
Cancer 2016 NCI 1R35CA197566-01 Mechanisms governing metastatic dormancy and reactivation GIANCOTTI, FILIPPO UNIVERSITY OF TX MD ANDERSON CAN CTR TX $959,998
Cancer 2016 NCI 1R35CA197707-01 Molecular basis for dietary chemoprevention CHAPKIN, ROBERT TEXAS A&M AGRILIFE RESEARCH TX $886,177
Cancer 2016 NCI 1R35CA197694-01 Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers TLSTY, THEA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $929,349
Cancer 2016 NCI 1R35CA197616-01 Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology KIRSCH, DAVID DUKE UNIVERSITY NC $942,807
Cancer 2016 NCI 1R35CA197731-01 Targeting Mutant KRAS for Cancer Therapy SEBTI, SAID H. LEE MOFFITT CANCER CTR & RES INST FL $960,504
Cancer 2016 NCI 1R35CA197628-01 Metabolic basis of B cell lineage leukemia relapse MUSCHEN, MARKUS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $653,813
Cancer 2016 NCI 1R35CA197709-01 New Ways of Targeting K-Ras MCCORMICK, FRANK UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $932,874
Cancer 2016 NIDCR 4R01DE023177-04 MicroRNAs in cleft lip and palate MARTIN, JAMES BAYLOR COLLEGE OF MEDICINE TX $566,179
Cancer 2016 NIEHS 4R01ES021110-05 Inflammasomes in pathogenesis of mesothelioma SHUKLA, ARTI UNIVERSITY OF VERMONT & ST AGRIC COLLEGE VT $343,125
Cancer 2016 NIAID 4R01AI099300-04 Metabolic regulation of T cell fate and tumor immunity PAN, FAN JOHNS HOPKINS UNIVERSITY MD $405,000
Cancer 2016 NIEHS 4R01ES015632-09 Roles of the RecQ Helicases BLM and RECQ5 in Genome Maintenance SUNG, PATRICK YALE UNIVERSITY CT $417,542
Cancer 2016 NIEHS 4R01ES019935-05 Novel Interactions of DNA Repair Processes in Replication Fork Maintenance COOPER, PRISCILLA UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB CA $407,588
Cancer 2016 NIEHS 4R01ES020591-05 Mechanisms of arsenic-induced chromosomal instability and carcinogenesis DAI, WEI NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $400,910
Cancer 2016 NIEHS 4R01ES020870-05 Cell survival and arsenic carcinogenesis SHI, XIANGLIN UNIVERSITY OF KENTUCKY KY $334,125
Cancer 2016 NIAID 5R01AI105114-03 Viral Interface with an Interferon-Induced Gene REICH, NANCY STATE UNIVERSITY NEW YORK STONY BROOK NY $463,541
Cancer 2016 NIEHS 5R01ES020868-03 Molecular Mechanism of Arsenic Carcinogenesis JIANG, BINGHUA THOMAS JEFFERSON UNIVERSITY PA $329,418
Cancer 2016 NIEHS 4R01ES021452-04 Role of human DNA polymerase iota in replicative bypass of DNA lesions AGGARWAL, ANEEL ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $443,702
Cancer 2016 NIEHS 5R01ES002710-35 Hydrolytic enzymes in the metabolism of toxins HAMMOCK, BRUCE UNIVERSITY OF CALIFORNIA AT DAVIS CA $412,465
Cancer 2016 NIAID 5R01AI115471-02 Gamma Delta T cell surveillance of metabolites as signals of cellular stress ADAMS, ERIN UNIVERSITY OF CHICAGO IL $389,432
Cancer 2016 NIEHS 5R01ES022606-03 Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes RUNGE-MORRIS, MELISSA WAYNE STATE UNIVERSITY MI $388,865
Cancer 2016 NIMHD 4P60MD000538-13 6307 Research Core TRINH-SHEVRIN, CHAU NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $146,456
Cancer 2016 NIAID 5UM1AI069421-10 GHESKIO HIV Clinical Trial Unit PAPE, JEAN GHESKIO CENTER HAITI $1,110,670
Cancer 2016 NIAID 5R01AI072194-07 Elucidation of Immunoglobulin Class Switch Recombination CHAUDHURI, JAYANTA SLOAN-KETTERING INST CAN RESEARCH NY $439,750
Cancer 2016 NIGMS 4R37GM056328-18 Electrophysiology of nuclear membrane InsP3 receptor FOSKETT, J. KEVIN UNIVERSITY OF PENNSYLVANIA PA $501,753
Cancer 2016 NIGMS 2R01GM047458-25 Roles of Cdc42 and its signaling partners in cell growth and differentiation CERIONE, RICHARD CORNELL UNIVERSITY NY $317,044
Cancer 2016 NIGMS 4R37GM056207-21 Simulation of Proton and Hydride Transfer in Enzymes HAMMES-SCHIFFER, SHARON UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $348,529
Cancer 2016 NIAID 5R21AI111125-02 Role of PRMT5 in HTLV-1 transformation and disease GREEN, PATRICK OHIO STATE UNIVERSITY OH $231,000
Cancer 2016 NIEHS 5R01ES005775-22 Hypoxia, DNA repair, and gene silencing GLAZER, PETER YALE UNIVERSITY CT $374,625
Cancer 2016 NIEHS 5R01ES025121-02 Biological Consequences and Repair of Alkylated Thymidine Lesions WANG, YINSHENG UNIVERSITY OF CALIFORNIA RIVERSIDE CA $342,000
Cancer 2016 NIAID 5R01AI114557-02 Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $612,662
Cancer 2016 NIA 4F32AG044946-03 Role of Cellular Senescence in Carcinogenesis ALIMIRAH, FATOUMA BUCK INSTITUTE FOR RESEARCH ON AGING CA $62,010
Cancer 2016 NIAID 5R01AI114556-02 Targeting Fnip1 to disrupt B cell development, metabolism, and transformation IRITANI, BRIAN UNIVERSITY OF WASHINGTON WA $395,376
Cancer 2016 NIBIB 5F31EB019883-02 Imaged guided drug delivery DEH, KOFI WEILL MEDICAL COLL OF CORNELL UNIV NY $40,938
Cancer 2016 NCI 4R01CA069202-20 Structure/Function of Protein Tyrosine Phosphatases ZHANG, ZHONG-YIN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $24,028
Cancer 2016 NCI 4R01CA072669-19 Cytotoxic-T-Lymphocyte (CTL) Therapy of AML BLAZAR, BRUCE UNIVERSITY OF MINNESOTA MN $294,076
Cancer 2016 NCI 4R01CA116753-10 Characterization of a DNA Polymerase Beta Deficient Mouse SWEASY, JOANN YALE UNIVERSITY CT $286,968
Cancer 2016 NCI 5R01CA132640-15 Role of heat shock factors (Hsfs) in tumorigenesis MIVECHI, NAHID GEORGIA REGENTS UNIVERSITY GA $270,000
Cancer 2016 NCI 5R01CA174305-03 Targeted Combination Therapy for Breast Cancer LI, SONG UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $313,504
Cancer 2016 NCI 5R01CA175052-03 Enhanced GBM Therapy Using a New Class of HSV Oncolytic Vector GRANDI, PAOLA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $316,018
Cancer 2016 NCI 5R01CA176001-03 Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis GROSSNIKLAUS, HANS EMORY UNIVERSITY GA $323,700
Cancer 2016 NCI 5R01CA182461-03 Defining the impact of clonal evolution on chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $362,378
Cancer 2016 NIDCR 4R01DE022291-05 KSHV infection of human tonsillar B cells KEDES, DEAN UNIVERSITY OF VIRGINIA VA $385,000
Cancer 2016 NIAID 4R01AI100987-04 Manipulation of inflammasomes and NF-kB signaling in human myeloid cells by Myxom MCFADDEN, GRANT UNIVERSITY OF FLORIDA FL $375,000
Cancer 2016 NCI 5R01CA181088-04 Obesity Affects Immunity to Kidney Cancer NORIAN, LYSE UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $293,212
Cancer 2016 NCI 5R01CA179044-03 Identification and modeling of driver genetic modules in glioblastoma IAVARONE, ANTONIO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $465,208
Cancer 2016 NCI 5R01CA182804-03 Enhancing Metabolic Oxidative Stress and Therapy Responses in Cancer Stem Cells SPITZ, DOUGLAS UNIVERSITY OF IOWA IA $338,391
Cancer 2016 NIAID 5R01AI058072-11 Structural Basis for Chemokine Function VOLKMAN, BRIAN MEDICAL COLLEGE OF WISCONSIN WI $344,250
Cancer 2016 NCI 4R01CA047296-28 A Pathway of Tumor Suppression LOZANO, GUILLERMINA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $249,580
Cancer 2016 NCI 4R01CA113381-12 Study the Role of Chfr in Tumorigenesis CHEN, JUNJIE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $272,318
Cancer 2016 NCI 1K22CA190653-01A1 p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer ALEXANDROVA, EVGUENIA STATE UNIVERSITY NEW YORK STONY BROOK NY $157,743
Cancer 2016 NCI 4R01CA050706-26 Molecular Pathophysiology of Thyroid Cell Growth FAGIN, JAMES SLOAN-KETTERING INST CAN RESEARCH NY $391,600
Cancer 2016 NCI 4R01CA068377-19 Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway XIONG, YUE UNIV OF NORTH CAROLINA CHAPEL HILL NC $332,383
Cancer 2016 NCI 4R01CA079954-16 Synthetic Regulators of Tyrosine Protein Kinases LAWRENCE, DAVID UNIV OF NORTH CAROLINA CHAPEL HILL NC $288,131
Cancer 2016 NCI 5R01CA163336-05 Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data SONG, JUN UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $329,064
Cancer 2016 NCI 5R01CA181413-03 Preventing tumor relapse with biomaterial-supported lymphocyte implants STEPHAN, MATTHIAS FRED HUTCHINSON CANCER RESEARCH CENTER WA $408,426
Cancer 2016 NIAID 4R01AI097320-04 Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID PORTEUS, MATTHEW STANFORD UNIVERSITY CA $393,000
Cancer 2016 NCI 5R01CA085344-17 Dynamic functions of DNA2 counteract DNA replication stresses and tumorigenesis SHEN, BINGHUI BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $294,000
Cancer 2016 NCI 4F30CA168323-04 Biological characterization of a novel class of lactate dehydrogenase A (LDH-A) i CALVARESI, EMILIA UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $48,120
Cancer 2016 NCI 5R01CA175313-03 The Role of MMP13 in Multiple Myeloma Bone Disease LENTZSCH, SUZANNE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $331,098
Cancer 2016 NCI 5R01CA181090-03 Regulation of DSB repair by 53BP1 DE LANGE, TITIA ROCKEFELLER UNIVERSITY NY $457,070
Cancer 2016 NCI 4K22CA178269-03 Quantify treatment response in IDH1 mutant glioma patients with metabolic MRI ANDRONESI, OVIDIU MASSACHUSETTS GENERAL HOSPITAL MA $200,418
Cancer 2016 NCI 5R01CA181185-03 Inhibition of CDC25B phosphatase by targeting protein-protein interactions CIERPICKI, TOMASZ UNIVERSITY OF MICHIGAN MI $316,863
Cancer 2016 NIDCR 4R01DE013173-15 Tumor Suppressor Qualities and Mechanisms of LZAP Activity YARBROUGH, WENDELL YALE UNIVERSITY CT $416,250
Cancer 2016 NIDCR 4R01DE022565-04 Mechanism regulating ErbB signaling network in head and neck cancer KRAMER, RANDALL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $396,250
Cancer 2016 NIDCD 5R01DC014428-02 Hedgehog signaling in maintaining taste organ structure and function: basic and clinical studies MISTRETTA, CHARLOTTE UNIVERSITY OF MICHIGAN MI $656,823
Cancer 2016 NIAID 5R01AI033993-22 Processed Antigen Characterization by Mass Spectrometry HUNT, DONALD UNIVERSITY OF VIRGINIA VA $624,957
Cancer 2016 NCI 5R01CA130996-08 Ubiquitination and the DNA Damage Response Pathway LOU, ZHENKUN MAYO CLINIC ROCHESTER MN $357,750
Cancer 2016 NCI 5R01CA132878-08 Post-translational Modifications in DNA Damage Response: a Structural Perspective MER, GEORGES MAYO CLINIC ROCHESTER MN $357,750
Cancer 2016 NCI 4R01CA133346-07 Regulation of Invadopodia Formation in Breast Cancer Cells KOLESKE, ANTHONY YALE UNIVERSITY CT $310,524
Cancer 2016 NCI 4R01CA164746-05 A causal role for asymmetric cell division defects in glioma initiation PETRITSCH, CLAUDIA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $320,588
Cancer 2016 NCI 4R13CA165625-05 CTRC-AACR San Antonio Breast Cancer Symposium KAKLAMANI, VIRGINIA UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $10,000
Cancer 2016 NCI 5R01CA174864-03 Nucleophilic Inhibitors for Targeting Redox-Sensitive Kinases CARROLL, KATE SCRIPPS FLORIDA FL $398,400
Cancer 2016 NIEHS 4R01ES015252-10 Homology-directed Chromosome Damage Repair via the BRCA2-PALB2 Axis SUNG, PATRICK YALE UNIVERSITY CT $408,894
Cancer 2016 NHLBI 5R00HL105779-04 The Role of Vascular Flt-1 in Endothelial-Pericyte Interactions CHAPPELL, JOHN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $243,145
Cancer 2016 NCI 5F30CA174329-02 Structural and molecular investigation of small molecule reactivation of p53 WALLENTINE, BRADLEY UNIVERSITY OF CALIFORNIA-IRVINE CA $48,576
Cancer 2016 NIAID 4R01AI072204-09 Cervical, Anal & Oral HPV Persistence/Adolescent Girls DIAZ, ANGELA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $780,197
Cancer 2016 NCI 4R37CA043460-33 Molecular Genetic Analysis of Colorectal Cancer VOGELSTEIN, BERT JOHNS HOPKINS UNIVERSITY MD $421,379
Cancer 2016 NCI 4R01CA051210-24 Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors ROSS, DAVID UNIVERSITY OF COLORADO DENVER CO $312,983
Cancer 2016 NCI 4U24CA055727-22 Childhood Cancer Survivor Study ARMSTRONG, GREGORY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $4,172,004
Cancer 2016 NCI 4R37CA076584-18 F-box proteins: deregulated cell cycle control and proteolysis in cancer PAGANO, MICHELE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $446,546
Cancer 2016 NCI 4R01CA164803-04 Role of CSN in the activity and dynamic cycling of cullin-RING ubiquitin ligases DESHAIES, RAYMOND CALIFORNIA INSTITUTE OF TECHNOLOGY CA $327,728
Cancer 2016 NCI 4R01CA172343-04 Digital Pathology_Accuracy Viewing Behavior and Image Characterization ELMORE, JOANN UNIVERSITY OF WASHINGTON WA $624,643
Cancer 2016 NIAMS 5R37AR027883-37 Cell adhesion and cytoskeletal dynamics in skin FUCHS, ELAINE ROCKEFELLER UNIVERSITY NY $785,316
Cancer 2016 NCI 4R01CA085180-15 Epstein-Barr Virus LMP1-Mediated Oncogenecity KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $762,316
Cancer 2016 NCI 5R01CA093405-14 Mouse Models of Gastric Cancer WANG, TIMOTHY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $325,782
Cancer 2016 NCI 5R01CA120206-11 Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer MEHTA, ANAND DREXEL UNIVERSITY PA $329,172
Cancer 2016 NCI 4R01CA125187-09 Translational Optimization of Bone Regeneration in the Irradiated Mandible BUCHMAN, STEVEN UNIVERSITY OF MICHIGAN MI $244,741
Cancer 2016 NCI 5R01CA125577-08 Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer. KLEER, CELINA UNIVERSITY OF MICHIGAN MI $349,875
Cancer 2016 NCI 4K08CA166510-04 Combination Therapy to Improve MAPK Pathway Inhibitor Efficacy in BRAF and KRAS M CORCORAN, RYAN MASSACHUSETTS GENERAL HOSPITAL MA $179,280
Cancer 2016 NCI 5R01CA132630-08 Chemical Probes for Metabolic Pathway Discovery in Human Disease CRAVATT, BENJAMIN SCRIPPS RESEARCH INSTITUTE CA $469,316
Cancer 2016 NCI 5R01CA181178-03 Regulation of polymerase switching in translesion synthesis MACHIDA, YUICHI MAYO CLINIC ROCHESTER MN $329,925
Cancer 2016 NIDDK 4F32DK101289-03 Investigation of Sox9 target genes in the pancreas BEER, REBECCA JOHNS HOPKINS UNIVERSITY MD $60,618
Cancer 2016 NIGMS 5R01GM041239-20 Enzymes of the Meta Fission Pathway WHITMAN, CHRISTIAN UNIVERSITY OF TEXAS, AUSTIN TX $280,130
Cancer 2016 NIGMS 5R01GM066817-12 The Biochemical Basis for the Mechanics of Cytokinesis ROBINSON, DOUGLAS JOHNS HOPKINS UNIVERSITY MD $311,243
Cancer 2016 NIBIB 1R01EB020125-01A1 Theranostic nanoparticles for detection and treatment of pancreatic cancer MCNALLY, LACEY UNIVERSITY OF LOUISVILLE KY $70,388
Cancer 2016 NIGMS 1R01EB020125-01A1 Theranostic nanoparticles for detection and treatment of pancreatic cancer MCNALLY, LACEY UNIVERSITY OF LOUISVILLE KY $320,000
Cancer 2016 NCI 2R01CA155117-07 Mutual Regulation of PTEN and P-REX2a in Normal and Cancer Cells PARSONS, RAMON ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $400,192
Cancer 2016 NCI 4R01CA071515-20 Integration of Retroviral DNA: Accessing Host Target DNA KATZ, RICHARD RESEARCH INST OF FOX CHASE CAN CTR PA $514,114
Cancer 2016 NCI 5R01CA073808-19 Ribonucleases in Cancer Chemotherapy RAINES, RONALD UNIVERSITY OF WISCONSIN-MADISON WI $327,117
Cancer 2016 NCI 5R01CA123031-08 Dynamic requirements of Ras signaling during cancer COUNTER, CHRISTOPHER DUKE UNIVERSITY NC $342,220
Cancer 2016 NCI 5R01CA175033-03 Host-tumor interactions and cancer relapse after radiation therapy WANG, XIANG-YANG VIRGINIA COMMONWEALTH UNIVERSITY VA $316,438
Cancer 2016 NHLBI 5R01HL037675-24 Regulation of Cardiac Myocyte Differentiation BADER, DAVID VANDERBILT UNIVERSITY TN $129,249
Cancer 2016 NHLBI 5R01HL095797-06 Interventions Against the Molecular Etiology of BMPR2-induced PAH WEST, JAMES VANDERBILT UNIVERSITY TN $107,899
Cancer 2016 NIAID 5R01AI079243-08 MicroRNA Function in the Immune System BALTIMORE, DAVID CALIFORNIA INSTITUTE OF TECHNOLOGY CA $416,250
Cancer 2016 NCI 5R01CA128943-08 Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancer DI CRISTOFANO, ANTONIO ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $396,625
Cancer 2016 NCI 5R01CA043054-29 Nuclear Function of Abl in DNA Damage Response WANG, JEAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $387,500
Cancer 2016 NCI 4F30CA174133-03 Mutant p53 has gain-of-function mechanisms to mediate tumor invasion LONG, APPLE UNIVERSITY OF PENNSYLVANIA PA $29,885
Cancer 2016 NCI 5R01CA182939-03 High resolution phase contrast endoscopy MERTZ, JEROME BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) MA $345,234
Cancer 2016 NIEHS 4R01ES020833-05 Genetic control of replication through DNA lesions in humans, and carcinogenesis PRAKASH, SATYA UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $344,250
Cancer 2016 NHLBI 5R01HL124209-02 Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis CROKER, BEN CHILDREN'S HOSPITAL CORPORATION MA $442,500
Cancer 2016 NCI 4R01CA120244-10 Oncogene c-Myc-dependent pathways in cutaneous melanoma03 NIKIFOROV, MIKHAIL ROSWELL PARK CANCER INSTITUTE CORP NY $320,405
Cancer 2016 NCI 4R01CA154562-05 Image-guided treatment planning for pleural Photodynamic Therapy ZHU, TIMOTHY UNIVERSITY OF PENNSYLVANIA PA $327,648
Cancer 2016 NCI 4R01CA164178-04 A novel NKG2D-specific BiTE cancer immunotherapy SENTMAN, CHARLES DARTMOUTH COLLEGE NH $336,150
Cancer 2016 NCI 4F30CA180601-03 The Role of p120ctn in Pancreatic Ductal Morphogenesis and Adenocarcinoma BAKIR, BASIL UNIVERSITY OF PENNSYLVANIA PA $29,932
Cancer 2016 NCI 5R01CA172106-05 Delta-like ligand 4+ dendritic cells and induction of alloimmunity ZHANG, YI TEMPLE UNIV OF THE COMMONWEALTH PA $323,700
Cancer 2016 NCI 4F31CA180749-03 Regulation of Human Papillomavirus Replication via Cell Signaling Pathways GRIEGO, ANASTACIA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $19,600
Cancer 2016 NCI 5R21CA181863-02 Dual PPARgamma/RXRalpha activator as novel anti-breast cancer therapy ORTIZ, MARIA TORREY PINES INST FOR MOLECULAR STUDIES FL $237,510
Cancer 2016 NCI 5R01CA190265-02 Copper metabolism as a unique vulnerability in cancer PETRIS, MICHAEL UNIVERSITY OF MISSOURI-COLUMBIA MO $345,224
Cancer 2016 NCI 5R21CA190344-02 Imaging endogenously produced tumor derived micro vesicles PITTET, MIKAEL MASSACHUSETTS GENERAL HOSPITAL MA $180,061
Cancer 2016 NCI 5R01CA190964-02 Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia VAN ETTEN, RICHARD UNIVERSITY OF CALIFORNIA-IRVINE CA $544,106
Cancer 2016 NCI 5R21CA191550-03 CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis SPIEGELMAN, VLADIMIR PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $156,893
Cancer 2016 NCI 4R01CA173712-04 Genetic circuits for high-throughput, multi-sensory, live cell microRNA prof WEISS, RON MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $497,596
Cancer 2016 NIEHS 4R01ES020668-05 Transgenic Models of Ah Receptor Action BRADFIELD, CHRISTOPHER UNIVERSITY OF WISCONSIN-MADISON WI $338,625
Cancer 2016 NIEHS 4R01ES020900-04 The Role of Aryl Hydrocarbon Receptor in Colon Tumorigenesis KENNEDY, GREGORY UNIVERSITY OF WISCONSIN-MADISON WI $334,989
Cancer 2016 NIEHS 5R21ES024863-02 Genome-wide detection of UV DNA damage by single molecule real time sequencing AGGARWAL, ANEEL ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $211,875
Cancer 2016 NHLBI 5K08HL118367-03 ELUCIDATING THE ROLE OF KRUPPEL LIKE FACTOR 7 IN T CELL DEVELOPMENT SCHUETTPELZ, LAURA WASHINGTON UNIVERSITY MO $26,438
Cancer 2016 NCI 4R01CA030276-34 IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES NIEDERKORN, JERRY UT SOUTHWESTERN MEDICAL CENTER TX $282,171
Cancer 2016 NCI 4P30CA033572-33 7390 Program Leadership FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $118,064
Cancer 2016 NCI 4P30CA033572-33 7397 Analytical Cytometry FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $124,312
Cancer 2016 NCI 4P30CA033572-33 7398 Analytical Pharmacology FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $101,467
Cancer 2016 NCI 4P30CA033572-33 7399 Bioinformatics FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $212,181
Cancer 2016 NCI 4P30CA033572-33 7400 Functional Genomics/Genomic Sequencing FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $276,604
Cancer 2016 NCI 5R01CA135650-07 Predictive Cancer Diagnostics and Therapy Response MOORE, ANNA MASSACHUSETTS GENERAL HOSPITAL MA $552,368
Cancer 2016 NCI 4P30CA033572-33 7401 Pathology FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $135,393
Cancer 2016 NCI 4P30CA033572-33 7402 Small Animal Imaging FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $78,569
Cancer 2016 NCI 4P30CA033572-33 7403 Drug Discovery & Structural Biology FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $198,106
Cancer 2016 NCI 4P30CA033572-33 7404 Survey Research FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $79,375
Cancer 2016 NCI 4P30CA033572-33 7405 Biostatistics FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $180,676
Cancer 2016 NCI 4P30CA033572-33 7406 Clinical Protocol and Data Management FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $259,469
Cancer 2016 NCI 4P30CA033572-33 7407 Protocol Review and Monitoring System FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $69,289
Cancer 2016 NCI 4P30CA033572-33 7408 Protocol-Specific Research Support FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $130,853
Cancer 2016 NCI 4P30CA033572-33 7409 Data and Safety Monitoring/ NIH Policy FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $75,109
Cancer 2016 NCI 4P30CA033572-33 7410 Senior Leadership FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $95,611
Cancer 2016 NCI 4P30CA033572-33 7411 Planning and Evaluation FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $59,911
Cancer 2016 NCI 4P30CA033572-33 7412 Developmental Funds FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $212,536
Cancer 2016 NCI 4P30CA033572-33 7413 Administration FRIEDMAN, MICHAEL BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $112,475
Cancer 2016 NCI 4R01CA158415-05 Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $367,787
Cancer 2016 NCI 5R01CA175741-03 Store-Operated Calcium Entry in Tumor Invasion and Metastasis YANG, SHENGYU H. LEE MOFFITT CANCER CTR & RES INST FL $73,855
Cancer 2016 NCI 4F31CA180738-03 Genetic and pharmacological manipulation of system xc in pancreatic cancer BADGLEY, MICHAEL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $43,120
Cancer 2016 NCI 4R01CA163793-05 Targeting the ICOS/ICOSL pathway to improve anti-tumor immune responses SHARMA, PADMANEE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $327,850
Cancer 2016 NCI 5R01CA182405-03 Erythropoietin receptor-driven tumor initiation and progression PARK, JIN MO MASSACHUSETTS GENERAL HOSPITAL MA $346,478
Cancer 2016 NCI 5R21CA191726-02 Therapeutic targeting of the B-cell lymphoma associated mutation MYD88-L265P SNYDER, GREG UNIVERSITY OF MARYLAND BALTIMORE MD $179,403
Cancer 2016 NCI 5R03CA191430-02 Organ specific macrophages and the regulation of disseminated tumor cell fate AGUIRRE-GHISO, JULIO ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $84,750
Cancer 2016 NEI 5R01EY024906-02 Transcriptional regulation of retinal mitochondrial function and cell cycle POCHE, ROSS BAYLOR COLLEGE OF MEDICINE TX $396,250
Cancer 2016 NIGMS 4R01GM095758-04 DNA mismatch repair in the nucleosomal environment KADYROV, FARID SOUTHERN ILLINOIS UNIVERSITY CARBONDALE IL $232,800
Cancer 2016 NIGMS 5R00GM101077-05 Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases MACGURN, JASON VANDERBILT UNIVERSITY TN $249,000
Cancer 2016 NINR 4F31NR014590-03 Cognitive Function and Breast Cancer: Genomics and Disease Characteristics KOLECK, THERESA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $18,734
Cancer 2016 NCI 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,100,000
Cancer 2016 NCI 5R01CA041101-31 Biologically Active Cyclic Peptides BOGER, DALE SCRIPPS RESEARCH INSTITUTE CA $405,056
Cancer 2016 NCI 4P30CA006516-51 6045 Leukemia LOOK, A. DANA-FARBER CANCER INST MA $93,191
Cancer 2016 NCI 4P30CA006516-51 6047 Lymphoma and Myeloma SHIPP, MARGARET DANA-FARBER CANCER INST MA $93,216
Cancer 2016 NCI 4P30CA006516-51 6050 Breast Cancer WINER, ERIC DANA-FARBER CANCER INST MA $93,190
Cancer 2016 NCI 4P30CA006516-51 6051 Gynecologic Cancers BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $93,366
Cancer 2016 NCI 4P30CA006516-51 6052 Prostate Cancer KANTOFF, PHILIP DANA-FARBER CANCER INST MA $93,226
Cancer 2016 NCI 4P30CA006516-51 6053 Translational Pharmacology and Early Therapeutic Trials KUFE, DONALD DANA-FARBER CANCER INST MA $93,190
Cancer 2016 NCI 4P30CA006516-51 6054 Gastrointestinal Malignancies FUCHS, CHARLES DANA-FARBER CANCER INST MA $93,190
Cancer 2016 NCI 4P30CA006516-51 6055 Lung Cancer CHRISTIANI, DAVID HARVARD SCHOOL OF PUBLIC HEALTH MA $92,567
Cancer 2016 NCI 4P30CA006516-51 6056 Neuro-Oncology MARTUZA, ROBERT MASSACHUSETTS GENERAL HOSPITAL MA $93,279
Cancer 2016 NCI 4P30CA006516-51 6057 Kidney Cancer ATKINS, MICHAEL BETH ISRAEL DEACONESS MEDICAL CENTER MA $91,136
Cancer 2016 NCI 5R01CA090668-13 FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia SMALL, DONALD JOHNS HOPKINS UNIVERSITY MD $291,600
Cancer 2016 NCI 4P30CA006516-51 6058 Cutaneous Oncology and Melanoma CHIN, LYNDA DANA-FARBER CANCER INST MA $85,327
Cancer 2016 NCI 4P30CA006516-51 6059 Cancer Cell Biology MCCLATCHEY, ANDREA MASSACHUSETTS GENERAL HOSPITAL MA $86,728
Cancer 2016 NCI 4P30CA006516-51 6060 Cancer Genetics DYSON, NICHOLAS MASSACHUSETTS GENERAL HOSPITAL MA $92,650
Cancer 2016 NCI 4P30CA006516-51 6061 Cancer Immunology DRANOFF, GLENN DANA-FARBER CANCER INST MA $93,190
Cancer 2016 NCI 4P30CA006516-51 6062 Biostatistics and Computational Biology PARMIGIANI, GIOVANNI DANA-FARBER CANCER INST MA $93,278
Cancer 2016 NCI 4P30CA006516-51 6064 Cancer Epidemiology HANKINSON, SUSAN BRIGHAM AND WOMEN'S HOSPITAL MA $82,450
Cancer 2016 NCI 4P30CA006516-51 6065 Cancer Risk and Disparities FRAZIER, A DANA-FARBER CANCER INST MA $92,979
Cancer 2016 NCI 4P30CA006516-51 6066 Outcomes Research AYANIAN, JOHN BRIGHAM AND WOMEN'S HOSPITAL MA $92,648
Cancer 2016 NCI 4P30CA006516-51 6073 Cancer Pharmacology SUPKO, JEFFREY MASSACHUSETTS GENERAL HOSPITAL MA $268,270
Cancer 2016 NCI 4P30CA006516-51 6074 Cell Manipulation RITZ, JEROME DANA-FARBER CANCER INST MA $323,768
Cancer 2016 NCI 4P30CA006516-51 6078 Tumor Imaging Metrics HARRIS, GORDON MASSACHUSETTS GENERAL HOSPITAL MA $287,072
Cancer 2016 NCI 4P30CA006516-51 6080 Cancer Proteomics LIBERMANN, TOWIA BRIGHAM AND WOMEN'S HOSPITAL MA $276,508
12345678910...


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer